お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
785777

スコポラミンの世界市場 - 市場規模、シェア、動向、市場動向、予測 ~2026年

Scopolamine Market - Size, Share, Trends, and Forecast to 2026

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 151 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.93円
スコポラミンの世界市場 - 市場規模、シェア、動向、市場動向、予測 ~2026年
出版日: 2018年07月17日
発行: Coherent Market Insights
ページ情報: 英文 151 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

スコポラミンは、抗コリン作用、制吐作用、抗喘息作用を有する医薬品で、経口薬、注射剤、眼用薬、局所用薬として入手可能です。

当レポートでは、世界のスコポラミン市場を調査し、市場の概要、剤形・流通経路・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査目的と前提条件

  • 調査目的
  • 仮定
  • 略語

第2章 市場の概要

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 市場スニペット:剤形別
    • 市場スニペット:流通経路別
    • 市場スニペット:地域別
  • コヒーレントオポチュニティマップ(COM)

第3章 市場力学、規制、動向分析

  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場機会
  • 影響分析
  • 市場動向
  • 主な開発動向
  • 疫学
  • 沿革
  • 医薬品の収益の可能性
  • ファイブフォース分析
  • PEST分析

第4章 世界のスコポラミン市場:剤形別

  • イントロダクション
  • タブレット
  • シロップ
  • 注射剤
  • パッチ
  • その他

第5章 世界のスコポラミン市場:流通チャネル別

  • イントロダクション
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第6章 世界のスコポラミン市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • アフリカ
  • 中東

第7章 競争環境

  • ヒートマップ解析
  • 企業プロファイル
    • Baxter International Inc.
    • GlaxoSmithKline plc
    • Novartis AG
    • Perrigo Company plc.
    • Caleb Pharmaceuticals, Inc.
    • Myungmoon Pharma Co. LTD.
    • Alchem International
    • Phytex Australia
    • Centroflora-Cms
    • Alkaloids of Australia
    • Fine Chemicals Corporation
  • アナリストの意見

第8章 セクション

  • 参考文献
  • 調査方法
  • Coherent Market Insightsについて
目次

Scopolamine is an oral, intravenous, ophthalmic or topical drug derived from plants of the nightshade family (Solanaceae), specifically Hyoscyamus Niger and Atropa belladonna, with anticholinergic, antiemetic and antivertigo properties.

It has applications in prevention of nausea, vomiting, and dizziness associated with motion sickness and recovery from anesthesia and surgery. Scopolamine may also be used to treat certain stomach or intestinal problems, such as spastic muscle states, diverticulitis, irritable bowel syndrome, Parkinson-like conditions etc.

Market Dynamics

Changing lifestyle that involves minimal or absolutely no physical work in a routine life are responsible for the malfunctioning of the digestive as well as gastrointestinal system. Increasing number of population adopting long-hour sedentary work lifestyle are likely to be affected with gastrointestinal disorders such as irritable bowel syndrome and thus are responsible to support growth of the global scopolamine market.

However, various side-effects observed while using these drugs such as retarded motion, drowsiness, and diluted pupils, may limit their growth to some extent in the near future.

Key features of the study:

This report provides in-depth analysis of the scopolamine market, market size (US$ Mn) and cumulative annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players

It profiles leading players in the global scopolamine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

Key players covered as a part of this study include Baxter International Inc., GlaxoSmithKline plc, Novartis AG, Perrigo Company plc, Caleb Pharmaceuticals, Inc., Myungmoon Pharma Co. LTD., Alchem International, Phytex Australia, Centroflora-Cms, Alkaloids of Australia, and Fine Chemicals Corporation.

Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics

The global scopolamine market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for scopolamine market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Scopolamine Market, By Dosage Form:
  • Tablet
  • Syrup
  • Injection
  • Patch
  • Others
  • Global Scopolamine Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Scopolamine Market, By Region:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Dosage Form:
  • Tablet
  • Syrup
  • Injection
  • Patch
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • By Dosage Form:
  • Tablet
  • Syrup
  • Injection
  • Patch
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Asia Pacific
  • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • By Dosage Form:
  • Tablet
  • Syrup
  • Injection
  • Patch
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • By Dosage Form:
  • Tablet
  • Syrup
  • Injection
  • Patch
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Dosage Form:
  • Tablet
  • Syrup
  • Injection
  • Patch
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Africa
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • By Dosage Form:
  • Tablet
  • Syrup
  • Injection
  • Patch
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Company Profiles
  • Baxter International Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • GlaxoSmithKline plc
  • Novartis AG
  • Perrigo Company plc.
  • Caleb Pharmaceuticals, Inc.
  • Myungmoon Pharma Co. LTD.
  • Alchem International
  • Phytex Australia
  • Centroflora-Cms
  • Alkaloids of Australia
  • Fine Chemicals Corporation
  • “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Dosage Form
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Epidemiology
  • Historical Overview
  • Revenue Potential of Drugs
  • PORTER'S Five Forces
  • PEST Analysis

4. Global Scopolamine Market, By Dosage Form, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Tablet
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Syrup
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Injection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Patch
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

5. Global Scopolamine Market, By Distribution Channel, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

6. Global Scopolamine Market, By Regions, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2016 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Northern Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Baxter International Inc.
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • GlaxoSmithKline plc
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Novartis AG
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Perrigo Company plc.
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Caleb Pharmaceuticals, Inc.
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Myungmoon Pharma Co. LTD.
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Alchem International
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Phytex Australia
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Centroflora-Cms
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Alkaloids of Australia
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Fine Chemicals Corporation
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.